Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 124 (1) , 28-34
- https://doi.org/10.1067/mtc.2002.121974
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Controlled and modulated release of basic fibroblast growth factorPublished by Elsevier ,2003
- Therapeutic angiogenesis in cardiology using protein formulationsCardiovascular Research, 2001
- Clinical Trials in Coronary Angiogenesis: Issues, Problems, ConsensusCirculation, 2000
- Infections, Inflammation, and the Risk of Coronary Heart DiseaseCirculation, 2000
- Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass SurgeryCirculation, 1999
- Angiogenesis Gene TherapyCirculation, 1999
- Angiogenesis in Cardiovascular DiseaseDrugs, 1999
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic PlaqueJournal of Cardiovascular Pharmacology, 1995
- Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic RetinopathyAmerican Journal of Ophthalmology, 1994